Recent Grants

  • Horvath (PI) NIH 1R21CA271066-01A1; 03/2023 - 02/2025; scSNVariome - single cell SNVs driving cancer dynamics
     
  • Lee (PI) NIH R37CA270536; 08/22 – 08/27; Understanding lactate catabolism by BACH1 in triple negative breast cancer
     
  • R. Li (MPI) NIH R01 CA282303; 07/2023 – 07/2028; T Cell-Specific BRCA1 Function in Antitumor Immunity and Immunotherapy
     
  • W. Li (MPI) NIH R01 HL168174; 04/2023 – 03/2027; Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci
     
  • Mazumder (Co-PI) NIH 1R24GM146616; 07/2022 – 07/2027; Computational and Informatics Resources and Tools for Glycoscience Research
     
  • Mazumder (Contact PI) VA 36C24E23D0006; 12/2022 – 12/2025; A Machine Learning-based Application for Informed Clinical Decision-making (PredictMod): Microbiome-centric Predictive Intervention for Veterans with Pre-diabetes
     
  • Mazumder (Contact PI) NIH 1OT2OD032092; 09/2023 – 09/2024; Molecular biomarker data collection, standardization, and integration with CFDE data for translational research
     
  • Sen (PI) Bohringer Ingelheim IIS; commence Nov 2023; Detection of Podocyte injury in African American Veterans, with diabetic (DKD) and non-diabetic chronic kidney disease (NDKD) in early phases of renal impairment 
     
  • Seto (PI) NIH R01CA270149; 01/2023 – 12/2027; Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
     
  • Seto (PI) ACS IRG-22-973396-01-IRG; 01/2023 – 12/2025; George Washington Cancer Center Institutional Research Grant
     
  • Shook (PI) NIH R01AR082417; 03/2023 – 02/2028; The role of GPR84 signaling during skin repair
     
  • Sweeney (PI) American Brain Tumor Association Discovery Grant; 09/23-09/24; Personalized Nanoparticle-Mediated T Cell Therapy for Glioblastoma
     
  • Wu (PI); NIH R01CA266432; 08/2022 – 07/2027; Molecular Function and Mechanism of ARID4B in ERalpha Signaling and Breast Cancer
     
  • Zhu (Contact PI) NIH R01CA275094; 03/23 – 07/28; Regulation of resistance to CDK4/6 inhibitor in breast cancer
     
  • Zhu (Contact PI) NIH R01CA258357; 2/2022-1/2027; The role of And-1 in nucleoside excision repair